-
1دورية أكاديمية
المؤلفون: Liao, Yunfei, Sassi, Slim, Halvorsen, Stefan, Feng, Yong, Shen, Jacson, Gao, Yan, Cote, Gregory, Choy, Edwin, Harmon, David, Mankin, Henry, Hornicek, Francis, Duan, Zhenfeng
وصف الملف: application/pdf
العلاقة: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338289/pdfTest/; Scientific Reports; Liao, Y., S. Sassi, S. Halvorsen, Y. Feng, J. Shen, Y. Gao, G. Cote, et al. 2017. “Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.” Scientific Reports 7 (1): 43941. doi:10.1038/srep43941. http://dx.doi.org/10.1038/srep43941Test.; http://nrs.harvard.edu/urn-3:HUL.InstRepos:32071950Test
الإتاحة: https://doi.org/10.1038/srep43941Test
http://nrs.harvard.edu/urn-3:HUL.InstRepos:32071950Test -
2دورية أكاديمية
المؤلفون: Gao, Yan, Shen, Jacson K., Choy, Edwin, Zhang, Zhan, Mankin, Henry J., Hornicek, Francis J., Duan, Zhenfeng
وصف الملف: application/pdf
العلاقة: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860631/pdfTest/; Scientific Reports; Gao, Yan, Jacson K. Shen, Edwin Choy, Zhan Zhang, Henry J. Mankin, Francis J. Hornicek, and Zhenfeng Duan. 2016. “Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats.” Scientific Reports 6 (1): 25659. doi:10.1038/srep25659. http://dx.doi.org/10.1038/srep25659Test.; http://nrs.harvard.edu/urn-3:HUL.InstRepos:27320319Test
الإتاحة: https://doi.org/10.1038/srep25659Test
http://nrs.harvard.edu/urn-3:HUL.InstRepos:27320319Test -
3دورية أكاديمية
المؤلفون: Yang, Xiaoqian, lyer, Arun K., Singh, Amit, Choy, Edwin, Hornicek, Francis J., Amiji, Mansoor M., Duan, Zhenfeng
وصف الملف: application/pdf
العلاقة: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330541/pdfTest/; Scientific Reports; Yang, Xiaoqian, Arun K. lyer, Amit Singh, Edwin Choy, Francis J. Hornicek, Mansoor M. Amiji, and Zhenfeng Duan. 2015. “MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.” Scientific Reports 5 (1): 8509. doi:10.1038/srep08509. http://dx.doi.org/10.1038/srep08509Test.; http://nrs.harvard.edu/urn-3:HUL.InstRepos:14065512Test
الإتاحة: https://doi.org/10.1038/srep08509Test
http://nrs.harvard.edu/urn-3:HUL.InstRepos:14065512Test -
4دورية أكاديمية
المؤلفون: Gao, Yan, Feng, Yong, Shen, Jacson K., Lin, Min, Choy, Edwin, Cote, Gregory M., Harmon, David C., Mankin, Henry J., Hornicek, Francis J., Duan, Zhenfeng
وصف الملف: application/pdf
العلاقة: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468826/pdfTest/; Scientific Reports; Gao, Yan, Yong Feng, Jacson K. Shen, Min Lin, Edwin Choy, Gregory M. Cote, David C. Harmon, Henry J. Mankin, Francis J. Hornicek, and Zhenfeng Duan. 2015. “CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.” Scientific Reports 5 (1): 11365. doi:10.1038/srep11365. http://dx.doi.org/10.1038/srep11365Test.; http://nrs.harvard.edu/urn-3:HUL.InstRepos:17295765Test
الإتاحة: https://doi.org/10.1038/srep11365Test
http://nrs.harvard.edu/urn-3:HUL.InstRepos:17295765Test